Jarrow says that compared to triglyceride-bound omega-3s, phospholipid omega-3s offer higher bioavailability.
Jarrow Formulas (Los Angeles) is taking its stake in the fish oil omega-3 market with PhosphOmega, a dietary supplement aimed at improving omega-3 bioavailability over orginary fish oils.
PhosphOmega gets its name from the product’s emphasis on a phospholipid delivery form. Jarrow says that compared to triglyceride-bound omega-3s, phospholipid omega-3s offer higher bioavailability.
“The omega-3s in seafood are consumed both as phospholipids and triglycerides,” says marketing director Rory Lipsky. “Eighty percent of the fat in trout is phospholipid and twenty percent is tiglyceride. PhosphOmega provides omega-3s in both the triglyceride and phospholipid forms, just as nature intended.”
Jarrow’s new fish oil also contains 100 mcg of astaxanthin “to support a healthy immune response.” Heavy metal and PCB testing ensure low levels in each product.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.